Gilder Gagnon Howe & Co’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.3M | Buy |
4,155,763
+59,712
| +1% | +$837K | 0.62% | 50 |
|
|
2025
Q1 | $64.1M | Buy |
4,096,051
+193,060
| +5% | +$3.02M | 0.84% | 39 |
|
|
2024
Q4 | $54.4M | Buy |
3,902,991
+349,153
| +10% | +$4.86M | 0.59% | 49 |
|
|
2024
Q3 | $33.1M | Sell |
3,553,838
-62,694
| -2% | -$583K | 0.4% | 63 |
|
|
2024
Q2 | $33.6M | Sell |
3,616,532
-618,419
| -15% | -$5.75M | 0.42% | 64 |
|
|
2024
Q1 | $42M | Buy |
+4,234,951
| New | +$42M | 0.52% | 51 |
|